Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:10 AM
Ignite Modification Date:
2025-12-25 @ 2:10 AM
NCT ID:
NCT04606160
Eligibility Criteria:
Patient and Caregiver Participants:
Inclusion Criteria:
* English speaking
* Patient and/or caregiver of patient between the ages of 7 years to less than 19 at time of enrollment
* Patient and/or caregiver of patient diagnosis of sickle cell disease with sickle cell - SS genotype
* Patient and/or caregiver of patient who has received chronic blood transfusions for at least 6 months and continuing through the duration of the study
* Caregiver and patient pair agree to both participate in the study
Exclusion Criteria:
* Patient or caregiver of patient who are temporarily on blood transfusions for a transient complication (e.g., priapism or recurrent acute chest syndrome)
* Patient and/or caregiver of patient displaying clinically evident cognitive delay (e.g., stroke with severe cognitive deficits, intellectual disability) that would preclude completion of measures or participation in intervention as defined by the medical team, researcher, or psychologist.
* Patient and/or caregiver of patient who is a ward of state
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
7 Years
Study:
NCT04606160
Study Brief:
Protocol Section:
NCT04606160